top of page
5TH ANNUAL BREAST CANCER SYMPOSIUM
DISPARITIES ON A CELLULAR LEVEL AND PATIENT LEVEL
COMMUNITY-BASED CANCER CARE AFFILIATE:
An Overview of Clinical Data for ENHERTU (fam-trastuzumab deruxtecan-nxki) in HER2-Expressing Metastatic Breast Cancer
Please join us for an informative, expert-led discussion presented by Daiichi Sankyo, Inc. and AstraZeneca to explore the data on the efficacy and safety of ENHERTU.
​
Provided by: Daiichi Sankyo Inc. and AstraZeneca
Quest Speaker: Francis Arena, MD
Affiliations: NYU Langone Arena Oncology
bottom of page